A. Shoemark (Dundee (Angus), United Kingdom), R. José (London, United Kingdom)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
The effects of fluticasone propionate in mice infected with Chlamydia pneumoniae
D. Paróczai (Deszk, Hungary), A. Sejben (Szeged, Hungary), D. Kókai (Szeged, Hungary), D. Virok (Szeged, Hungary), V. Endrész (Szeged, Hungary), K. Burián (Szeged, Hungary)
|   |
Glycine efficacy for prevention or treatment on LPS-acute lung injury in mice
R. Righetti (São Paulo (SP), Brazil), B. Goto (São Paulo (SP), Brazil), T. Santos (São Paulo (SP), Brazil), L. Camargo (São Paulo (SP), Brazil), B. Saraiva-Romanholo (São Paulo (SP), Brazil), S. Bezerra (São Paulo (SP), Brazil), E. Leick (São Paulo (SP), Brazil), C. Prado (São Paulo (SP), Brazil), M. Martins (São Paulo (SP), Brazil), R. Nogueira (São Paulo (SP), Brazil), J. Neto (São Paulo (SP), Brazil), D. Souza (São Paulo (SP), Brazil), B. Salu (São Paulo (SP), Brazil), M. Oliva (São Paulo (SP), Brazil), I. Tibério (São Paulo (SP), Brazil)
| |
Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in vivo
J. Kong (Nanning, China), J. Luo (Nanning, China), K. Wang (Nanning, China), H. Lu (Nanning, China), S. Cai (Nanning, China), L. Liu (Nanning, China)
| |
Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis
A. Abdul Wahab (Doha, Qatar), E. Ibrahim (Doha, Qatar), A. Sultan (Doha, Qatar), J. Jass (Doha, Qatar), M. Sid Ahmed (Doha, Qatar)
| |
Non-typeable Haemophilus influenzae biofilm formation on air-liquid interface cultured primary human airway epithelia
K. Horton (Southampton, United Kingdom), R. Allan (Leicester, United Kingdom), J. Coles (Southampton, United Kingdom), J. Hueppe (Southampton, United Kingdom), D. Cleary (Southampton, United Kingdom), C. Jackson (Southampton, United Kingdom), J. Lucas (Southampton, United Kingdom)
| |
Single-cell-sequencing in SARS-COV-2-infected hamsters sheds light on endothelial cell involvement in COVID-19
G. Nouailles (Berlin, Germany), E. Wyler (Berlin, Germany), P. Pennitz (Berlin, Germany), D. Postmus (Berlin, Germany), D. Vladimirova (Berlin, Germany), J. Kazmierski (Berlin, Germany), F. Pott (Berlin, Germany), K. Dietert (Berlin, Germany), M. Muelleder (Berlin, Germany), V. Farztdinov (Berlin, Germany), B. Obermayer (Berlin, Germany), S. Wienhold (Berlin, Germany), S. Andreotti (Berlin, Germany), T. Hoefler (Berlin, Germany), B. Sawitzki (Berlin, Germany), C. Drosten (Berlin, Germany), L. Sander (Berlin, Germany), N. Suttorp (Berlin, Germany), M. Ralser (Berlin, Germany), D. Beule (Berlin, Germany), A. Gruber (Berlin, Germany), C. Goffinet (Berlin, Germany), M. Landthaler (Berlin, Germany), J. Trimpert (Berlin, Germany), M. Witzenrath (Berlin, Germany)
| |
Decreased neutrophil phagocytosis and killing of bacteria in COVID-19 patients
M. Nomani (Tehran, Islamic Republic of Iran), M. Varahram (Tehran, Islamic Republic of Iran), M. Ghazi (Tehran, Islamic Republic of Iran), I. Adcock (London , United Kingdom), E. Mortaz (Tehran, Islamic Republic of Iran)
| |
Cathelicidin as a marker of worsening of the course of lung infection
T. Luchnikova (Blagoveshchensk (Amur Oblast), Russian Federation), O. Prikhodko (Blagoveshchensk (Amur Oblast), Russian Federation), I. Menshikova (Blagoveshchensk (Amur Oblast), Russian Federation), T. Talchenkova (Blagoveshchensk (Amur Oblast), Russian Federation)
| |
Inducible epithelial resistance modulates innate antiviral signaling against coronavirus and influenza
J. Pantaleón García (Houston, United States of America), L. Yusem-Cartens (Houston, United States of America), V. Kulkarni (Houston, United States of America), S. Walii (Houston, United States of America), M. Longmire (Houston, United States of America), Y. Wang (Houston, United States of America), S. Evans (Houston, United States of America)
| |
The role of efflux pump systems and OprD porine in antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients with bronchiectasis
R. Cabrera (Barcelona, Spain), L. Fernández-Barat (Barcelona, Spain), N. Vázquez (Barcelona, Spain), V. Alcaráz (Barcelona, Spain), R. López-Aladid (Barcelona, Spain), L. Bueno (Barcelona, Spain), R. Amaro (Barcelona, Spain), P. Oscanoa (Barcelona, Spain), L. Muñoz (Barcelona, Spain), J. Vila (Barcelona, Spain), A. Torres (Barcelona, Spain)
| |
From cell cultures to autopsies: study on functionality across different experimental models in SARS-CoV-2 infection.
M. Arroyo Varela (Málaga, Spain), B. Delgado-Martín (Málaga, Spain), E. Salcedo Lobera (Málaga, Spain), E. Espinosa García (Málaga, Spain), R. Larrosa Jiménez (Málaga, Spain), R. Bautista Moreno (Málaga, Spain)
| |
Impact of SARS-CoV-2 heat inactivation on active protease biomarkers in sputum sol
C. Mcgranaghan (Belfast (Belfast), United Kingdom), P. Weir (Belfast (Belfast), United Kingdom), D. Mccafferty (Belfast (Belfast), United Kingdom), K. Moffitt (Belfast (Belfast), United Kingdom), T. Ferguson (Belfast (Belfast), United Kingdom)
| |
Ciliary videomicroscopy at room temperature might lack sensitivity for primary ciliary dyskinesia diagnosis
N. Bricmont (Liège, Belgium), R. Bonhiver (Liège, Belgium), L. Benchimol (Liège, Belgium), M. Pirotte (Liège, Belgium), C. Moermans (Liège, Belgium), A. Poirrier (Liège, Belgium), P. Lefèbvre (Liège, Belgium), R. Louis (Liège, Belgium), M. Seghaye (Liège, Belgium), C. Kempeneers (Liège, Belgium)
| |
Late Breaking Abstract - Immunomodulatory and clinical effects of RIPK1 inhibitor SAR443122 in patients with severe COVID-19
P. Clot (Chilly-Mazarin, France), C. Farenc (Montpellier, France), B. Suratt (Cambridge, United States of America), T. Krahnke (Frankfurt, Germany), A. Tardat (Montpellier, Germany), P. Florian (Frankfurt, Germany), R. Pomponio (Framingham, United States of America), N. Patel (Cambridge, United States of America), M. Wiekowski (Bridgewater, United States of America), Y. Lin (Bridgewater, United States of America), B. Terrier (Paris, France), H. Staudinger (Bridgewater, United States of America)
| |
Late Breaking Abstract - Analysis of volatile organic compounds in post-COVID-19 patients with eNose technology.
B. van Raaij (Leiden, Netherlands), J. Hameete (Leiden, Netherlands), J. Stöger (Leiden, Netherlands), M. Ninaber (Leiden, Netherlands), J. Geelhoed (Leiden, Netherlands)
| |
Late Breaking Abstract - Impact of COVID-19 on patients with severe alpha1 antitrypsin deficiency: the IMCA1 study of the EARCO ERS Clinical Research Collaboration, preliminary findings.
D. Parr (Coventry (West Midlands), United Kingdom), C. Clarenbach (Zurich, Switzerland), J. Chorostowska-Wynimko (Warsaw, Poland), A. Corsico (Pavia, Italy), I. Ferrarotti (Pavia, Italy), L. Lázaro-Asegurado (Burgos, Spain), J. Lopez-Campos (Seville, Spain), A. Rozy (Warsaw, Poland), A. Sark (Leiden, Netherlands), M. Sucena (Porto, Portugal), J. Stolk (Leiden, Netherlands), E. Tabernero Huguet (Biocruces-Bizkaia, Spain), H. Tanash (Lund, Sweden), M. Miravitlles (Barcelona, Spain)
| |
Late Breaking Abstract - A single centre observational study of inflammatory biomarkers in Covid 19 and clinically important outcomes
I. Sau (Wolverhampton, United Kingdom), E. Qureshi (Wolverhampton, United Kingdom), D. Mears (Wolverhampton, United Kingdom), S. Ejiofor (Wolverhampton, United Kingdom)
| |
Late Breaking Abstract - Recombinant Panton-Valentine leukocidin induced dysregulation of cytokines secretion of human alveolar macrophage is not mediated by necrotic effect.
X. Shi (GuangZhou, China), Y. Shi (GuangZhou, China), W. Zhang (GuangZhou, China), J. Liang (GuangZhou, China), B. Wu (GuangZhou, China)
| |
Late Breaking Abstract - Capture efficiency of mechanically nebulised synthetic nanoparticles, liposomes, SARS-CoV-2 virus-like particles, and infectious pseudotyped virions is influenced by particle surface charge
J. Henderson (Newcastle Upon Tyne, United Kingdom), R. Gross (Ulm, Germany), S. Moschos (Newcastle Upon Tyne, United Kingdom), S. Ali (Newcastle Upon Tyne, United Kingdom), T. Mantso (Newcastle Upon Tyne, United Kingdom), E. Wright (Brighton, United Kingdom), J. Mueller (Ulm, Germany), J. Muench (Ulm, Germany)
| |